Literature DB >> 26205358

[Osteosarcomatous dedifferentiated chondrosarcoma].

P-U Tunn1, M Werner2.   

Abstract

A secondary peripheral chondrosarcoma (SPC) evolving from an osteochondroma is rare, but it has been described several times. The development of an osteosarcomatous dedifferentiated chondrosarcoma in a locally recurrent SPC is extremely rare. The following case report of a 46-year-old man demonstrates and discusses this phenomenon.

Entities:  

Keywords:  Exostosis; Local recurrence; Neoplasm grading; Neoplastic cell transformation; Second primary neoplasms

Mesh:

Year:  2015        PMID: 26205358     DOI: 10.1007/s00132-015-3143-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  14 in total

1.  A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.

Authors:  Giovanni Grignani; Emanuela Palmerini; Silvia Stacchiotti; Antonella Boglione; Virginia Ferraresi; Sergio Frustaci; Alessandro Comandone; Paolo G Casali; Stefano Ferrari; Massimo Aglietta
Journal:  Cancer       Date:  2010-10-05       Impact factor: 6.860

2.  Secondary chondrosarcoma of the pelvis arising from a solitary exostosis in an 11-year-old patient: a case report with 5-year follow-up.

Authors:  Lukas M Nystrom; Barry R DeYoung; Jose A Morcuende
Journal:  Iowa Orthop J       Date:  2013

3.  Secondary chondrosarcoma in osteochondromas. Medullary extension in 15 of 45 cases.

Authors:  P I Wuisman; P C Jutte; T Ozaki
Journal:  Acta Orthop Scand       Date:  1997-08

4.  Low-grade chondrosarcoma of long bones treated with intralesional curettage followed by application of phenol, ethanol, and bone-grafting.

Authors:  Suzan H M Verdegaal; Hugo F G Brouwers; Erik W van Zwet; Pancras C W Hogendoorn; Antonie H M Taminiau
Journal:  J Bone Joint Surg Am       Date:  2012-07-03       Impact factor: 5.284

5.  Advanced chondrosarcomas: role of chemotherapy and survival.

Authors:  A Italiano; O Mir; A Cioffi; E Palmerini; S Piperno-Neumann; C Perrin; L Chaigneau; N Penel; F Duffaud; J E Kurtz; O Collard; F Bertucci; E Bompas; A Le Cesne; R G Maki; I Ray Coquard; J Y Blay
Journal:  Ann Oncol       Date:  2013-10-07       Impact factor: 32.976

6.  Secondary chondrosarcoma in osteochondroma: report of 107 patients.

Authors:  Adel Refaat Ahmed; Tai-Sheng Tan; K Krishnan Unni; Mark S Collins; Doris E Wenger; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2003-06       Impact factor: 4.176

7.  Survival analysis of patients with chondrosarcomas of the pelvis.

Authors:  Andreas F Mavrogenis; Andrea Angelini; Gabriele Drago; Biagio Merlino; Pietro Ruggieri
Journal:  J Surg Oncol       Date:  2013-05-16       Impact factor: 3.454

8.  Long-term results of intralesional curettage and cryosurgery for treatment of low-grade chondrosarcoma.

Authors:  Morteza Meftah; Patricia Schult; Robert M Henshaw
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

9.  Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.

Authors:  Murat Altay; Kenan Bayrakci; Yusuf Yildiz; Selim Erekul; Yener Saglik
Journal:  J Orthop Sci       Date:  2007-09-28       Impact factor: 1.601

10.  Surgical treatment of central grade 1 chondrosarcoma of the appendicular skeleton.

Authors:  Domenico Andrea Campanacci; Guido Scoccianti; Alessandro Franchi; Giuliana Roselli; Giovanni Beltrami; Massimiliano Ippolito; Giuseppe Caff; Filippo Frenos; Rodolfo Capanna
Journal:  J Orthop Traumatol       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.